agilon health (AGL) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Executive summary
Annual meeting scheduled for June 2, 2026, with virtual participation available to shareholders.
Shareholders are encouraged to review proxy materials and vote by June 1, 2026.
Voting matters and shareholder proposals
Election of three Class II directors: Diana McKenzie, Karen Mcloughlin, and Ron Williams.
Ratification of Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2026.
Advisory vote on executive compensation for named executive officers.
Provision for other business to be addressed as may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Partial view of Summaries dataset, powered by Quartr API
Latest events from agilon health
- Profitability surged in Q1 2026, prompting raised full-year guidance and strong liquidity.AGL
Q1 20267 May 2026 - Tim O'Rourke named CEO and Director with new compensation terms; no changes to voting matters.AGL
Proxy filing27 Apr 2026 - Proxy covers director elections, auditor ratification, pay-for-performance, and ESG priorities.AGL
Proxy filing23 Apr 2026 - 2026 guidance targets breakeven EBITDA and $5.5B revenue after cost discipline and transformation.AGL
Q4 20257 Apr 2026 - Shareholders approved a reverse stock split and adjournment proposal, both backed by the Board.AGL
EGM 202617 Mar 2026 - Transformation, data-driven care, and disciplined contracting set the stage for growth and stability.AGL
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Disciplined contracting, cost controls, and clinical programs drive margin gains amid elevated trends.AGL
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Stockholders to vote on a reverse stock split, reducing shares to as low as 16.6 million.AGL
Proxy Filing20 Feb 2026 - Virtual vote on reverse stock split and adjournment proposal to maintain NYSE compliance.AGL
Proxy Filing18 Feb 2026